Navigation Links
Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
Date:11/1/2007

approximately $25 million and restructuring charges of approximately

$15 million. There could be additional charges excluded from the

Company's GAAP net loss, to arrive at non-GAAP net income, which are

dependent on unknown future events and are difficult to predict and

estimate at this time.

Contacts:

Kyle Kuvalanka (investors) Jennifer Snyder (media)

(617) 761-4734 (617) 444-1439

Millennium Pharmaceuticals, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

(in thousands, except per share

amounts)

Revenues:

Net product sales $70,360 $53,161 $191,550 $165,320

Revenue under strategic

alliances 10,628 17,196 38,168 82,990

Royalties 41,344 33,737 116,617 98,382

Total revenues 122,332 104,094 346,335 346,692

Costs and expenses:

Cost of sales 6,931 6,730 17,668 36,660

Research and development (Note 1) 72,551 73,436 217,162 235,343

Selling, general and

administrative (Note 1) 42,949 34,365 129,506 107,221

Restructuring 1,667 1,352 13,050 5,737

Amortization of intangibles 8,488 8,488 25,462 25,462

Total costs and expenses 132,586 124,371 402,848 410,423

Loss from operations (10,254) (20,277) (56,513) (63,731)

Other income (expense):

Investment in
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Francisco, California (PRWEB) July 31, 2014 ... systems that inform therapeutic decision-making in oncology, today announced ... August 14, 2014 to discuss the Company's financial results ... provide an update about the business in the current ... audio call beginning on Thursday, August 14, 2014, at ...
(Date:7/31/2014)... 31, 2014 Rancho BioSciences , ... of Omicsoft’s Array Suite with tranSMART . ... able to send data in tranSMART to Array Suite ... versions of tranSMART including the new 1.2 release. ... and storage for the analysis of high dimensional quantification ...
(Date:7/31/2014)... MA (PRWEB) July 31, 2014 ... (UC) and collaboration company, is proud to announce ... (LMS). LMS complements Adobe Connect’s elearning tools to ... LMS delivers content with training tools for desktop ... eLearning with LMS is the perfect online training ...
(Date:7/30/2014)... TARRYTOWN, N.Y. and PARIS ... REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today ... Food and Drug Administration (FDA) rare pediatric disease priority ... (BLA) submission for alirocumab.  The priority review voucher entitles ... which provides for an expedited 6-month review from the ...
Breaking Biology Technology:CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3SoundConnect Enhances Portfolio with Adobe Connect Learning Management System (LMS) 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6
... , SOUTH PLAINFIELD, N.J., Sept. 2 PTC ... its option to collaborate on advancing drug discovery efforts on ... (Gene Expression Modulation by Small-molecules) technology. , , ... , , In September 2007, Celgene made ...
... , SAN DIEGO, Sept. 2 Results from ... developmental product candidates will be presented at the ... held at The Moscone Center in San Francisco on September 12-15, 2009. ... , , , Fidaxomicin ...
... , SOUTH SAN FRANCISCO, Calif., Sept. ... the first commercial sales of a new 20 microgram per ... York Heart Association Class III and IV pulmonary arterial hypertension ... Ventavis in half the volume, which is expected to reduce ...
Cached Biology Technology:PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration 2Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting 2Optimer Pharmaceuticals Announces Presentations of Additional Phase 3 Fidaxomicin and Prulifloxacin Data at Upcoming ICAAC Annual Meeting 3Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States 2Actelion Launches Increased Strength Formulation of Ventavis (Iloprost) for Pulmonary Arterial Hypertension in the United States 3
(Date:7/30/2014)... researchers from the University of Helsinki and the Universitat ... in mice morphological changes which have taken millions of ... the embryonic development of mice teeth, induced in the ... similar to those observed in the fossil registry of ... ago. , To modify the development of their ...
(Date:7/30/2014)... University associate professor Andrew S. Mount, performed cutting-edge research ... for novel anti-fouling paint for ships and boats and ... The team,s findings, published in Nature Communications ... that attaches to a wide variety of surfaces using ... an underwater heavy-duty adhesive. , "In previous research, we ...
(Date:7/30/2014)... Limited today announced an across-the-board increase in Impact ... 2013 InCites Journal Citation Reports (Thomson Reuters, 2014) ... Journal , Essays in Biochemistry , ... all received increases in their Impact Factors. ... and published by Portland Press Limited. , 2014 ...
Breaking Biology News(10 mins):Scientists reproduce evolutionary changes by manipulating embryonic development of mice 2Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Across-the-board Impact Factor increases for Portland Press Limited 2
... Studying thousands of patients, Japanese researchers have found a ... three cancers esophageal, head and neck, and lung. ... of developing these diseases. In the May issue ... the American Association for Cancer Research, scientists from Aichi ...
... A Swiss marine biologist and an Australian quantum physicist have ... Reef, Australia, can see a world invisible to all other ... have shown that mantis shrimp not only have the ability ... but have optimal polarisation vision a first for any ...
... in the February 2008 issue of HortScience offers new ... athletic fields ready for fall sports more quickly. Results ... pare down the usual 9- to 12-month waiting period ... autumn football traffic. Dr. John Stier, Associate Professor ...
Cached Biology News:Tooth loss strongly linked to risk of esophageal, head and neck, and lung cancer 2Shrimps see beyond the rainbow 2Shrimps see beyond the rainbow 3Establishing faster-growing, durable football fields 2
... Linkage: This CLS number ... created to easily match Cornings ... availability yet, please order under ... or contact customer service for ...
... Linkage: This CLS number ... created to easily match Cornings ... availability yet, please order under ... or contact customer service for ...
ID clarifier: With ethidium bromide (50 μg/ml)...
... cultured in DMEM and harvested at the log ... the antigens in their native forms, cells were ... on a 12-well (5 mm) adhesive coated slide, ... cellular attachment and to minimize background staining. ...
Biology Products: